- Home
- ERAS vs GHLD Comparison
ERAS vs GHLD Comparison
Compare ERAS & GHLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- GHLD
- Stock Information
- Founded
- ERAS 2018
- GHLD 1960
- Country
- ERAS United States
- GHLD United States
- Employees
- ERAS N/A
- GHLD N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- GHLD Finance: Consumer Services
- Sector
- ERAS Health Care
- GHLD Finance
- Exchange
- ERAS Nasdaq
- GHLD Nasdaq
- Market Cap
- ERAS 723.8M
- GHLD 831.7M
- IPO Year
- ERAS 2021
- GHLD 2020
- Fundamental
- Price
- ERAS $2.49
- GHLD $13.64
- Analyst Decision
- ERAS Strong Buy
- GHLD Buy
- Analyst Count
- ERAS 5
- GHLD 5
- Target Price
- ERAS $5.90
- GHLD $16.30
- AVG Volume (30 Days)
- ERAS 1.2M
- GHLD 10.2K
- Earning Date
- ERAS 11-12-2024
- GHLD 11-06-2024
- Dividend Yield
- ERAS N/A
- GHLD 3.72%
- EPS Growth
- ERAS N/A
- GHLD N/A
- EPS
- ERAS N/A
- GHLD N/A
- Revenue
- ERAS N/A
- GHLD $829,864,000.00
- Revenue This Year
- ERAS N/A
- GHLD $37.55
- Revenue Next Year
- ERAS N/A
- GHLD $29.77
- P/E Ratio
- ERAS N/A
- GHLD N/A
- Revenue Growth
- ERAS N/A
- GHLD 4.51
- 52 Week Low
- ERAS $1.64
- GHLD $12.78
- 52 Week High
- ERAS $3.45
- GHLD $18.26
- Technical
- Relative Strength Index (RSI)
- ERAS 38.71
- GHLD 40.27
- Support Level
- ERAS $2.51
- GHLD $13.63
- Resistance Level
- ERAS $2.68
- GHLD $13.98
- Average True Range (ATR)
- ERAS 0.22
- GHLD 0.26
- MACD
- ERAS -0.05
- GHLD 0.05
- Stochastic Oscillator
- ERAS 10.00
- GHLD 26.03
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About GHLD Guild Holdings Company
Guild Holdings Co is a growth-oriented mortgage company. It operates in two segments; The origination segment operates its loan origination business throughout the United States. It is responsible for loan origination, acquisition, and sale activities. This segment is further divided into retail and correspondent channel, and The servicing segment provides a steady stream of cash flow to support the origination segment more importantly it allows for the Company to build long-standing client relationships that drive repeat and referral business back to the origination segment to recapture the client's next mortgage transaction. It is responsible for the servicing activities of all loans in its servicing portfolio. It generates a majority of its revenue from the Origination segment.